At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Active-Controlled Study of Patients With Cardiovascular Disease and Diabetes Mellitus Not Adequately Controlled With Simvastatin or Atorvastatin: Comparison of Switching to Combination Tablet Ezetimibe/Simvastatin Versus Switching to Rosuvastatin or Doubling the Statin Dose
In Brief
A Phase 3 clinical trial evaluating ezetimibe (+) simvastatin, simvastatin 40 mg or atorvastatin 20 mg, and 2 other interventions for Cardiovascular Disorder and Diabetes Mellitus. Completed, enrolled 808 participants.
Detailed Summary
The purpose of this study is to determine the efficacy of switching to a combination tablet ezetimibe/simvastatin (10mg/20mg) versus rosuvastatin (10 mg) versus doubling the statin dose in those patients who have cardiovascular disease and diabetes mellitus not adequately controlled on simvastatin 20 mg or atorvastatin 10 mg.
Study Details
Timeline
Interventions
ezetimibe/simvastatin 10/20 mg tablets, taken once daily for six weeks.
simvastatin 40 mg or atorvastatin 20 mg tablets, taken once daily for six weeks.
rosuvastatin 10 mg tablets, taken once daily for six weeks.
All patients will take atorvastatin 10 mg tablets OR simvastatin 20 mg tablets, taken once daily in a 6-week screening/stabilization period prior to randomization.